This site is intended for healthcare professionals only
LoginRegister

Maharashtra to establish Life Sciences Innovation and Incubation Centre

Written By : Ruchika Sharma   |  
DCC Flags State-Level Gaps, Calls for Nationwide Uniform Enforcement of Drug Quality Standards
  • whatsapp
  • Telegram

Mumbai: In a bold move to supercharge its pharmaceutical and biotech ecosystem, the Maharashtra government is gearing up to establish a Life Sciences Innovation and Incubation Centre, FDA Minister Narahari Zirwal has said.

After a meeting at Mantralaya, Zirwal noted, "Biotechnology is set to play a critical role in strengthening Maharashtra's health sciences ecosystem, with the state government preparing to establish a state-of-the-art Life Sciences Innovation and Incubation Centre aimed at accelerating research and development in the pharmaceutical sector."

The proposed centre will serve as a major catalyst in transforming Maharashtra into a global hub for health, pharmaceutical, and biotech innovation, he said, adding that it would also attract investment into the state.

The innovation and incubation centre will help attract greater investment into the state's pharmaceutical manufacturing industry, PTI reported.
Zirwal said states, such as Gujarat, Andhra Pradesh and Himachal Pradesh, have already set up similar research hubs, while public-private partnerships are being used to develop formulation labs for biological and chemical research in pharmaceuticals.
Maharashtra must move swiftly to maintain leadership in innovative drug manufacturing, he said.
The proposed centre will support cutting-edge work in pharma, biotech, medical devices, diagnostics, and digital health, and provide startups with access to modern laboratories, technical expertise and funding.
"The innovation park is the need of the hour. It will keep Maharashtra at the forefront of innovative drug development
," Zirwal said. He said this centre will help attract greater investment into the state's pharmaceutical manufacturing industry, create employment opportunities, and strengthen training and mentorship for emerging startups.
Positioned as a world-class research institution, it will support development of globally competitive pharmaceutical products.
Narahari ZirwalFDA
Source : with inputs
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    X